Synaffix, a Lonza company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs), licensed its ADC technology to BigHat Biosciences ...
Explore the latest developments showcased at World ADC, highlighting smarter payloads and precise targeting in drug discovery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results